CN1098701C - Synthetic orall liquid of red sage root - Google Patents
Synthetic orall liquid of red sage root Download PDFInfo
- Publication number
- CN1098701C CN1098701C CN99112197A CN99112197A CN1098701C CN 1098701 C CN1098701 C CN 1098701C CN 99112197 A CN99112197 A CN 99112197A CN 99112197 A CN99112197 A CN 99112197A CN 1098701 C CN1098701 C CN 1098701C
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- medicinal liquid
- recipe
- cardiovascular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses an oral medicinal liquid of traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. The oral medicinal liquid is formed into tincture by synthesizing single recipes A, B, C which are separately stir-fried, wherein the recipe A is compounded from red sage root, astragalus root, ginseng, Chuanxiong rhizome, the recipe B is honey, and the recipe C is compounded from musk and bezoar. In the formula of the present invention, the oral medicinal liquid is synthesized by compounding separately stir-fried medicines for suppressing hyperactive liver and calming endogenous wind, promoting blood circulation and removing blood stasis, lowering blood pressure and stimulating heart, and alleviating fever and relieving toxin on the basis of supplementation. The oral medicinal liquid is used for treating various symptoms caused by cardiovascular and cerebrovascular diseases, and has the advantages of good curative effect, small oral taking dose, rapid effect taking, no side effect and sanitary use.
Description
The present invention relates to a kind of Chinese medicine, is a kind of Chinese medicine tincture for the treatment of cardiovascular and cerebrovascular disease specifically.
Cardiovascular and cerebrovascular disease belongs to old common disease, and is as hypertension, coronary heart disease, arteriosclerosis, hemiplegia etc., very big to human health damage, there is not highly effective Drug therapy for this class disease at present, can only relief of symptoms, the need that have are taken for a long time to keep effect, can not effect a radical cure.In addition, Chinese patent medicines of some treatment cardiovascular and cerebrovascular diseases mostly are pill or capsule, make trouble, and oral dose is big, the patient with after easily cause gastrointestinal upset, absorb slowly, produce effects is slow, will catch in the while use and touch medicine, not really health.
The purpose of this invention is to provide the synthetic tincture of a kind of Chinese medicine, the various disease conditions that causes for cardiovascular and cerebrovascular disease has remarkable result, reduces oral dose, and produce effects is fast, has no side effect.
The present invention is made by following materials of weight proportions medicine:
250~300 parts of Radix Salviae Miltiorrhizaes, 250~300 parts of the Radixs Astragali, 250~300 parts of Radix Ginsengs, 200~300 parts of Rhizoma Chuanxiongs, 200~300 parts in Radix Rehmanniae Preparata, 200~250 parts of Radix Angelicae Sinensis, 200~250 parts of Radix Saposhnikoviaes, 150~200 parts of Radix Puerariaes, 60~100 parts at antelope angle, 150~200 parts of Radix Notoginseng, 200~250 parts of Radix Achyranthis Bidentataes, 250~300 parts of Rhizoma Dioscoreae Septemlobae, 150~200 parts of Resina sophorae, 200~250 parts on Flos Carthami, 50~100 parts of Herba Schizonepetae, 50~100 parts of Herba Menthaes, 200~250 parts of Cortex Magnoliae Officinalis, 200~250 parts of Fructus Aurantii Immaturuss, 200~250 parts of Fructus Crataegis, 60~100 parts of Hirudos, 250~300 parts in Radix Glycyrrhizae; 1000 parts of Mel; 10~15 parts in Moschus, 20~30 parts of Calculus Boviss.
The present invention's prescription is on the basis of tonification, associate with suppressing the hyperactive liver to relieve the wind syndrome, blood circulation promoting and blood stasis dispelling, blood pressure lowering heart tonifying, the medication combined of heat-clearing and toxic substances removing, branch is processed synthetic, the vascular fragility of reduction and permeability are arranged, it is thick to alleviate the sticking blood of erythrocyte aggregation and anticoagulant, reduction blood, improves the microcirculation of vitals such as the heart, brain, kidney, lung, regulates tissue repair and regeneration, strengthen the metabolism of human body, strengthen the effect of myocardial contraction and circulation blood vessels.The various diseases that are mainly used in cardiovascular and cerebrovascular disease and cause, as hypertension, coronary heart disease, angina pectoris, sensation of oppression over the chest with shortness of breath, headache and dizzy, cerebral infarction, hemiplegia, numbness of hands and feet, spoken unclear etc., viral cardiomyopathy, pulmonary heart disease, rheumatism also there is certain curative effect.Adopt to divide simultaneously to process to synthesize tincture, the suitable expansion content of medicine of respectively distinguishing the flavor of improves the concentration of finished product, makes oral dose little, and produce effects is rapid, and patient's medication no pain has no side effect, and uses also much cleaner.Existing nearly hundred cardiovascular and cerebrovascular vessel patients used this medicine, obvious effective rate 100%, and untoward reaction did not appear in cure rate about 85%.
Be described in detail the present invention below in conjunction with embodiment.
Get Radix Salviae Miltiorrhizae 250g, Radix Astragali 250g, Radix Ginseng 250g, Rhizoma Chuanxiong 200g, Radix Rehmanniae Preparata 200g, Radix Angelicae Sinensis 200g, Radix Saposhnikoviae 200g, Radix Puerariae 150g, antelope angle 60g, Radix Notoginseng 150g, Radix Achyranthis Bidentatae 200g, Rhizoma Dioscoreae Septemlobae 250g, Resina sophorae 150g, Flos Carthami 200g, Herba Schizonepetae 50g, Herba Menthae 50g, Cortex Magnoliae Officinalis 200g, Fructus Aurantii Immaturus 200g, Fructus Crataegi 200g, Hirudo 60g, Radix Glycyrrhizae 250g, above raw material ground be smalls, process with the 10kg decocting, the extracting juice post precipitation that removes slag, clear juice is put into container, and clean meter is no more than 5kg; Get high-quality Mel 1000g again, fry in shallow oil into iron pan and put into the container cooling after dark brown; Get Moschus 10g, Calculus Bovis 20g, put into glass container, after the dissolving of 300g warm water, seal half an hour.Said components is synthesized after preparing, and is about to each component medicinal liquid and puts into container and mix well sealing and get final product.Last available 100 milliliters Clear glass bottles and jars packing should be adorned 55~60 bottles.Final drug is Umber, sticking shape, and bitter in the mouth is sweet.
Usage and consumption: oral one time 5~10 milliliters, day clothes secondary or follow the doctor's advice.With preceding medicine is shaken up.Treat that sb.'s illness took a favorable turn (10~20 days), use instead once a day, take continuously.Apoplexy sequela, anemia of pregnant woman's forbidding.Storage and preservation: storage life 1 year is deposited at ventilation, shady and cool place.
Claims (1)
1, a kind of Chinese medicine preparation for the treatment of cardiovascular and cerebrovascular disease is characterized in that being made by following materials of weight proportions medicine:
250~300 parts of Radix Salviae Miltiorrhizaes, 250~300 parts of the Radixs Astragali, 250~300 parts of Radix Ginsengs, 200~300 parts of Rhizoma Chuanxiongs, 200~300 parts in Radix Rehmanniae Preparata, 200~250 parts of Radix Angelicae Sinensis, 200~250 parts of Radix Saposhnikoviaes, 150~200 parts of Radix Puerariaes, 60~100 parts at antelope angle, 150~200 parts of Radix Notoginseng, 200~250 parts of Radix Achyranthis Bidentataes, 250~300 parts of Rhizoma Dioscoreae Septemlobae, 150~200 parts of Resina sophorae, 200~250 parts on Flos Carthami, 50~100 parts of Herba Schizonepetae, 50~100 parts of Herba Menthaes, 200~250 parts of Cortex Magnoliae Officinalis, 200~250 parts of Fructus Aurantii Immaturuss, 200~250 parts of Fructus Crataegis, 60~100 parts of Hirudos, 250~300 parts in Radix Glycyrrhizae; 1000 parts of Mel; 10~15 parts in Moschus, 20~30 parts of Calculus Boviss.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99112197A CN1098701C (en) | 1999-05-08 | 1999-05-08 | Synthetic orall liquid of red sage root |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN99112197A CN1098701C (en) | 1999-05-08 | 1999-05-08 | Synthetic orall liquid of red sage root |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1273122A CN1273122A (en) | 2000-11-15 |
CN1098701C true CN1098701C (en) | 2003-01-15 |
Family
ID=5275526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN99112197A Expired - Fee Related CN1098701C (en) | 1999-05-08 | 1999-05-08 | Synthetic orall liquid of red sage root |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1098701C (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296078C (en) * | 2005-06-09 | 2007-01-24 | 邱电相 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular disease |
CN1907320B (en) * | 2005-08-04 | 2010-07-07 | 吉林康乃尔药业有限公司 | Traditional Chinese medicine compound, processes for preparing traditional Chinese medicine therefrom and use thereof |
CN100512858C (en) * | 2006-11-24 | 2009-07-15 | 王建兴 | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases |
CN103202895B (en) * | 2013-04-25 | 2014-12-03 | 赵彦强 | Spray for treating heart disease |
CN105125996A (en) * | 2015-10-05 | 2015-12-09 | 南京多宝生物科技有限公司 | Pharmaceutical preparation for treating unstable angina pectoris of aged coronary heart disease |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1110176A (en) * | 1995-01-19 | 1995-10-18 | 余练康 | Oral drug for curing diabetes and complicated angiocardiopathy |
CN1142952A (en) * | 1994-12-17 | 1997-02-19 | 李高寅 | Glossy ganoderma oral liquor and its preparing method |
CN1200278A (en) * | 1997-05-26 | 1998-12-02 | 万福源 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
-
1999
- 1999-05-08 CN CN99112197A patent/CN1098701C/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1142952A (en) * | 1994-12-17 | 1997-02-19 | 李高寅 | Glossy ganoderma oral liquor and its preparing method |
CN1110176A (en) * | 1995-01-19 | 1995-10-18 | 余练康 | Oral drug for curing diabetes and complicated angiocardiopathy |
CN1200278A (en) * | 1997-05-26 | 1998-12-02 | 万福源 | Traditional Chinese medicine prepn. for treating cardiovascular and cerebrovascular disease |
Also Published As
Publication number | Publication date |
---|---|
CN1273122A (en) | 2000-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107029146A (en) | A kind of clearing lung and eliminating phlegm air making-up and spleen enlivening supports Chinese medicine composition of lung and preparation method thereof | |
CN102406911B (en) | Chinese medicine preparation for treating coronary heart disease | |
CN101961401B (en) | Compound Chinese medicinal composition having effects of reducing weight, reducing fat, tonifying spleen and beautifying | |
CN101485803B (en) | Chinese medicinal composition for treating menoxenia and dysmenorrhea | |
CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
CN104784347A (en) | Health-preserving medicinal liquor and manufacturing method thereof | |
CN103041200B (en) | Traditional Chinese medicine composition for treating cerebral hemorrhage | |
CN1098701C (en) | Synthetic orall liquid of red sage root | |
CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
CN105031244A (en) | Healthcare wine and preparation method thereof | |
CN1285378C (en) | Nourishing wine for regulating human body balance function | |
CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
CN104367926A (en) | Traditional Chinese medicine preparation for treating predawn diarrhea and preparation method thereof | |
CN104258359A (en) | Traditional Chinese medicine combination for curing pregnancy reaction and preparation method of preparations thereof | |
CN1134839A (en) | Medicated wine for expelling wind | |
CN106266106A (en) | The Chinese medicine preparation for the treatment of atrophic gastritis | |
CN101810771A (en) | Chinese medicinal preparation for curing coronary heart disease and angina pectoris | |
CN105031300A (en) | Medical wine with effects of dispelling wind and removing dampness and manufacturing method of medical wine | |
CN106074912B (en) | Chinese medicinal preparation for treating cardiovascular and cerebrovascular diseases | |
CN1059336C (en) | Oral liquor for curing senile dementia and constipation | |
CN105031087A (en) | Medical wine with effects of dispelling wind and removing dampness and manufacturing method of medical wine | |
CN101129767A (en) | Codonopsis pilosula and ophiopogon root decoction | |
CN104547369A (en) | Oral medicine for treating blepharospasm and preparation method thereof | |
CN103550548A (en) | Traditional Chinese medicinal composition for treating constipation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20030115 |